MAPT and disseminated peritoneal leiomyomatosis: Moreover, complex interactions with other biomarkers (e.g., total-tau; α-synuclein; Aβ42), for which distinct profiles have been recently highlighted between LPD and RPD patients [66, 67] might explain these results.